Summary
Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Asia-Pacific pharmaceuticals market had total revenues of $358.3bn in 2020, representing a compound annual growth rate (CAGR) of 9.4% between 2016 and 2020.
- Given the strong global demand for vaccines to protect citizens and control the spread of COVID-19, it is likely that pharmaceutical companies offering safe and effective therapeutic solutions will generate significant revenues, boosting overall growth in the market.
- Government initiatives, such as Made in China 2025 and the Production-Linked Incentive Scheme in India, are helping to drive growth in the market.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Asia-Pacific pharmaceuticals market by value in 2020?
- What will be the size of the Asia-Pacific pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Asia-Pacific's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. Is there any significant M&A activity on the horizon for next year?
8 Company Profiles
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceutical Co Ltd
8.3. Daiichi Sankyo Co Ltd
8.4. Takeda Pharmaceutical Company Limited
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20
Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Asia-Pacific pharmaceuticals market share: % share, by value, 2020
Table 5: Yangtze River Pharmaceutical Group: key facts
Table 6: Yangtze River Pharmaceutical Group: Key Employees
Table 7: Shanghai Pharmaceutical Co Ltd: key facts
Table 8: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Shanghai Pharmaceutical Co Ltd: Key Employees
Table 10: Daiichi Sankyo Co Ltd: key facts
Table 11: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 12: Daiichi Sankyo Co Ltd: Key Employees
Table 13: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 14: Takeda Pharmaceutical Company Limited: key facts
Table 15: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 16: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 17: Takeda Pharmaceutical Company Limited: Key Employees
Table 18: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 19: Asia-Pacific exchange rate, 2016-20
List of Figures
Figure 1: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20
Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2020
Figure 10: Asia-Pacific pharmaceuticals market share: % share, by value, 2020
